Microbial taxa related to skin aging.
Eculizumab biosimilar by Turgut Ilaclari for Neuromyelitis Optica (Devic’s Syndrome): Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes